Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Petry

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
British Journal of Cancer|April 17, 2019
Reduction of cervical cancer incidence within a primary HPV screening pilot project (WOLPHSCREEN) in Wolfsburg, GermanyJohannes Horn, Agnieszka Denecke, Alexander Luyten, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 20, 2007
An economic analysis of human papillomavirus triage for the management of women with atypical and abnormal Pap smear results in GermanySara K Sheriff, K Ulrich Petry, Hans Ikenberg, et al.
BMC Infectious Diseases|December 25, 2012
Prevalence of low-risk HPV types and genital warts in women born 1988/89 or 1983/84 -results of WOLVES, a population-based epidemiological study in Wolfsburg, GermanyKarl Ulrich Petry, Alexander Luyten, Annika Justus, et al.
Journal of Medical Virology|February 19, 2010
Evaluation of the performance of the novel PapilloCheck HPV genotyping test by comparison with two other genotyping systems and the HC2 testBetti Schopp, Barbara Holz, Manola Zago, et al.
Journal of Medical Virology|March 28, 2007
Prevalence of human papillomavirus types in women screened by cytology in GermanyStefanie J Klug, Meike Hukelmann, Bettina Hollwitz, et al.
BMC Cancer|August 14, 2013
Annual Papanicolaou screening for 5 years among human papillomavirus-negative womenKarl Ulrich Petry, Franziska Rinnau, Gerd Böhmer, et al.
American Journal of Obstetrics and Gynecology|December 4, 2014
A randomized study of hexaminolevulinate photodynamic therapy in patients with cervical intraepithelial neoplasia 1/2Peter Hillemanns, Francisco Garcia, Karl Ulrich Petry, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 5, 2010
Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 yearsAlexander Luyten, Sarah Scherbring, Axel Reinecke-Lüthge, et al.
Lasers in Surgery and Medicine|May 7, 2014
Efficacy and safety of hexaminolevulinate photodynamic therapy in patients with low-grade cervical intraepithelial neoplasiaPeter Hillemanns, Karl-Ulrich Petry, Philipp Soergel, et al.
American Journal of Obstetrics and Gynecology|July 16, 2003
No confirmed case of human papillomavirus DNA-negative cervical intraepithelial neoplasia grade 3 or invasive primary cancer of the uterine cervix among 511 patientsGerd Böhmer, Adriaan J C van den Brule, Oliver Brummer, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
British Journal of Cancer|April 17, 2019
Reduction of cervical cancer incidence within a primary HPV screening pilot project (WOLPHSCREEN) in Wolfsburg, GermanyJohannes Horn, Agnieszka Denecke, Alexander Luyten, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 20, 2007
An economic analysis of human papillomavirus triage for the management of women with atypical and abnormal Pap smear results in GermanySara K Sheriff, K Ulrich Petry, Hans Ikenberg, et al.
BMC Infectious Diseases|December 25, 2012
Prevalence of low-risk HPV types and genital warts in women born 1988/89 or 1983/84 -results of WOLVES, a population-based epidemiological study in Wolfsburg, GermanyKarl Ulrich Petry, Alexander Luyten, Annika Justus, et al.
Journal of Medical Virology|February 19, 2010
Evaluation of the performance of the novel PapilloCheck HPV genotyping test by comparison with two other genotyping systems and the HC2 testBetti Schopp, Barbara Holz, Manola Zago, et al.
Journal of Medical Virology|March 28, 2007
Prevalence of human papillomavirus types in women screened by cytology in GermanyStefanie J Klug, Meike Hukelmann, Bettina Hollwitz, et al.
BMC Cancer|August 14, 2013
Annual Papanicolaou screening for 5 years among human papillomavirus-negative womenKarl Ulrich Petry, Franziska Rinnau, Gerd Böhmer, et al.
American Journal of Obstetrics and Gynecology|December 4, 2014
A randomized study of hexaminolevulinate photodynamic therapy in patients with cervical intraepithelial neoplasia 1/2Peter Hillemanns, Francisco Garcia, Karl Ulrich Petry, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 5, 2010
Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 yearsAlexander Luyten, Sarah Scherbring, Axel Reinecke-Lüthge, et al.
Lasers in Surgery and Medicine|May 7, 2014
Efficacy and safety of hexaminolevulinate photodynamic therapy in patients with low-grade cervical intraepithelial neoplasiaPeter Hillemanns, Karl-Ulrich Petry, Philipp Soergel, et al.
American Journal of Obstetrics and Gynecology|July 16, 2003
No confirmed case of human papillomavirus DNA-negative cervical intraepithelial neoplasia grade 3 or invasive primary cancer of the uterine cervix among 511 patientsGerd Böhmer, Adriaan J C van den Brule, Oliver Brummer, et al.
Pageof 8